Bandingkan Harga & Kinerja Surya Biru Murni Acetylene Tbk. (SBMA) vs Organon Pharma Indonesia Tbk. (SCPI)
Kinerja harga (24 Jam Terakhir)
Statistik utama
Statistik utama
Perbedaan Surya Biru Murni Acetylene Tbk. dan Organon Pharma Indonesia Tbk.: Surya Biru Murni Acetylene Tbk. diperdagangkan di Rp111 (kapitalisasi pasar 101,36 M, volume 24 jam 1,37 jt), sedangkan Organon Pharma Indonesia Tbk. diperdagangkan di Rp29.000 (kapitalisasi pasar 104,4 M). Perbedaan utamanya: Surya Biru Murni Acetylene Tbk. dan Organon Pharma Indonesia Tbk. berukuran mirip dari sisi kapitalisasi pasar. Mana yang lebih baik tergantung tujuan investasimu.
| SBMA | SCPI | |
|---|---|---|
Kapitalisasi Pasar | 101,36 M | 104,4 M |
Volume | 1,37 jt | — |
Lot | 13,68 rb | — |
Perputaran | 148,72 jt | — |
Harga Rata-rata | 108,68 | — |
Nilai Transaksi | 148,72 jt | — |
Harga Ekuilibrium Indikatif | 111 | — |
Volume Ekuilibrium Indikatif | 1,25 rb | — |
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Berita terkini
Berita terbaru kedua aset
Berita terkini
Berita terbaru kedua aset
Tentang Surya Biru Murni Acetylene Tbk.
PT Surya Biru Murni Acetylene Tbk (the Company) was established in Balikpapan based on Notarial Deed No. 57 of Mohamad Rasjid Umar, S.H., dated October 25, 1980. The Company started its commercial operations in 1982.
Selengkapnya di halaman SBMA →Tentang Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Selengkapnya di halaman SCPI →
